BDBM208692 US9266876, 159
SMILES: C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccc(CO)cc2[nH]1
InChI Key: InChIKey=OHNXVUFHHKQXKE-OAHLLOKOSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CXCR3A / G protein (Galpha(16)) (Homo sapiens (Human)) | BDBM208692 (US9266876, 159) | UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Actelion Pharmaceuticals Ltd. US Patent | Assay Description The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the... | US Patent US9266876 (2016) BindingDB Entry DOI: 10.7270/Q2DB80NB | |||||||||||
More data for this Ligand-Target Pair |